Fred Hutch is an independent, nonprofit organization that also serves as the cancer program for UW Medicine.
This unique relationship allows for enhanced care coordination with one of the world’s leading integrated health systems while accelerating the latest scientific breakthroughs in cancer and other life-threatening diseases.
Fred Hutch is proud to raise funds that fuel the adult oncology program on behalf of both Fred Hutch and UW Medicine.
Fred Hutch researchers are attacking cancer from every angle. We are studying the basic biology of both healthy cells and cancer cells to disrupt illness, exploring the link between genetics and cancer, using new technologies to unlock the powerful information hidden in enormous data sets, and harnessing the immune system to fight disease. Your contribution helps make it possible.
Our work includes:
Our scientists are discovering new ways to tap into the immune system’s disease-fighting power, including new options for people facing solid tumor cancers.
Fred Hutch data and lab researchers collaborate to harness advances in machine learning and artificial intelligence to identify cancer risk, detect disease and customize treatment.
Deciphering cancer at the genetic and molecular level is allowing us to improve diagnoses, treatments and therapies targeted to the individual patient.
Fred Hutch investigators are advancing our understanding of the basic biology of life processes, including the cellular and molecular mechanisms behind cancer and other diseases.
We conduct research on cancer survivorship to guide care for cancer survivors and learn more about the challenges they face after their treatment ends.
To address inequities in health, care, research and other areas, Fred Hutch is committed to reducing health disparities, improving access to treatment and changing institutional practices.
Fred Hutch’s Public Health Sciences division, one of the most highly acclaimed cancer prevention programs in the country, conducts rigorous research to help people stay healthier.
We work to improve treatment of serious infections among cancer patients; halt COVID-19, HIV and other infectious diseases; and intercept viruses and infections that can cause cancer.
— Dr. Thomas J. Lynch, Jr., Fred Hutch president and director and holder of the Raisbeck Endowed Chair
Fred Hutch’s 5,700 employees, including more than 245 research faculty, are united by a passion for discovery, deep humanity and a commitment to cures. Fred Hutch’s scientific and clinical teams provide bench-to-bedside research and care. Supported by state-of-the-art facilities, they generate discoveries and translate them into advanced therapies, clinical practices and public health approaches.
When you give to Fred Hutch, you join a community dedicated to an urgent mission — improving lives.
As a cancer survivor herself, postdoctoral research fellow Dr. Denise Buenrostro knows the importance of the research conducted every day at Fred Hutch.
“When I survived cancer, I decided to take my second chance at life and do something that was going to make a difference. I chose to dedicate my life to finding therapies that would increase cancer patients’ survival and quality of life.”
As part of the Chapuis Lab, Dr. Buenrostro works to develop T cells — a type of immune cell — that identify and eliminate life-threatening viral infections and malignancies from patients who have received blood stem cell transplants.